Peng Tang

3.0k citations
120 papers · 1.7k indexed · h-index 21
Topics
Esophageal Cancer Research and Treatment (47 papers)Gastric Cancer Management and Outcomes (31 papers)Esophageal and GI Pathology (14 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Peng Tang

107 papers receiving 1.7k citations

Peers

Peng Tang
Comparison fields: 5 of 115
  • Molecular Biology 578
  • Surgery 541
  • Oncology 490
  • Pulmonary and Respiratory Medicine 455
  • Cancer Research 314
Replace Ning Shi with:
Ning Shi China
Vesa Kärjä Finland
Jun Sang Bae South Korea
Ye Tao China
Rayman Choo-Wing United States
Giusy Elia Italy
Martin Volkmann Germany
R. Dean Hautamaki United States
Miwa Uzuki Japan
Peng Tang relative to Ning Shi China Ning Shi's profile →
Citations per field
00.5×2.7×
Ning Shi · 1×
Citations per year

Countries citing papers authored by Peng Tang

Since Specialization
Citations

This map shows the geographic impact of Peng Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Tang more than expected).

Fields of papers citing papers by Peng Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Tang. The network helps show where Peng Tang may publish in the future.

Co-authorship network of co-authors of Peng Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Tang. A scholar is included among the top collaborators of Peng Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Tang. Peng Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 14
5 5
6 2
7 1
8 3
9 1
10 1
11 6
12 8
13 11
14 34
15 12
16 16
17 17
18 1
19 1
20
Expression and significance of estrogen receptor isoforms in different breast tissues
1

About Peng Tang

Peng Tang is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 120 papers that have together received 1.7k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (47 papers), Gastric Cancer Management and Outcomes (31 papers) and Esophageal and GI Pathology (14 papers). The work is most often cited by research in Cancer Research (314 citations), Oncology (490 citations) and Pulmonary and Respiratory Medicine (455 citations). Peng Tang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zhentao Yu, Keqiang Chen, Wanghua Gong, Zhiyao Bao, Teizo Yoshimura, Hongdian Zhang, Hongjing Jiang, Xiaobin Shang, Lei Gong and Chuangui Chen. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026